In hepatocellular carcinoma (HCC), a unique signature of Cyclin A2 or E1 activating alterations associated with an aggressive HCC subtype and characterized by structural rearrangements with hundreds of tandem duplications and templated insertions frequently activating the TERT promoter has been reported38. Here, TERT is linked to hepatocellular carcinoma.